It is impossible to reduce thromboembolic events without affecting normal hemostasis and increasing the risk of major bleeds, giving DOACs a narrow therapeutic window. Evidence of why DOACs cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback